{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:57:11Z","timestamp":1777543031160,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.urolonc.2008.02.016","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T04:51:44Z","timestamp":1213851104000},"page":"451-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Familial and genetic risk of transitional cell carcinoma of the urinary tract"],"prefix":"10.1016","volume":"26","author":[{"given":"Christine M.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Caporaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.urolonc.2008.02.016_bib2","series-title":"Bladder Cancer","author":"Silverman","year":"2006"},{"key":"10.1016\/j.urolonc.2008.02.016_bib3","series-title":"Cancer Facts and Figures 2007","year":"2007"},{"key":"10.1016\/j.urolonc.2008.02.016_bib4","series-title":"Urothelial Tumors of the Urinary Tract","author":"Messing","year":"2002"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q","article-title":"The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies","volume":"89","author":"Zeegers","year":"2000","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2008.02.016_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrc1190","article-title":"Tobacco carcinogens, their biomarkers, and tobacco-induced cancer","volume":"3","author":"Hecht","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2008.02.016_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.smj.0000247266.10393.72","article-title":"An updated review of the literature: Risk factors for bladder cancer with focus on occupational exposures","volume":"99","author":"Olfert","year":"2006","journal-title":"South Med J"},{"issue":"5 Pt 2","key":"10.1016\/j.urolonc.2008.02.016_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0190-9622(95)90435-2","article-title":"Genitourinary tumors in men with the Muir-Torre syndrome","volume":"33","author":"Davis","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djh058","article-title":"Lifetime risks of common cancers among retinoblastoma survivors","volume":"96","author":"Fletcher","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30065","article-title":"Tumor predisposition in Costello syndrome","volume":"137","author":"Gripp","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1464-410X.2003.04048.x","article-title":"Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer","volume":"91","author":"Ong","year":"2003","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijc.10191","article-title":"Familial aggregation of urothelial cell carcinoma","volume":"98","author":"Aben","year":"2002","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.urolonc.2008.02.016_bib13","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.23037","article-title":"Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers","volume":"121","author":"Randi","year":"2007","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2008.02.016_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1055-9965.EPI-06-0743","article-title":"Risk of bladder cancer associated with family history of cancer: Do low-penetrance polymorphisms account for the increase in risk?","volume":"16","author":"Murta-Nascimento","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6193","key":"10.1016\/j.urolonc.2008.02.016_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.2.6193.798-b","article-title":"Genetic association with bladder cancer","volume":"2","author":"Cartwright","year":"1979","journal-title":"Br Med J"},{"issue":"21","key":"10.1016\/j.urolonc.2008.02.016_bib16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ijc.2910350602","article-title":"Familial and environmental interactions in bladder cancer risk","volume":"35","author":"Kantor","year":"1985","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0022-5347(01)64821-3","article-title":"Familial transitional cell carcinoma among the population of Iceland","volume":"157","author":"Kiemeney","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001648-199103000-00010","article-title":"Familial aggregation of bladder cancer stratified by smoking status","volume":"2","author":"Kramer","year":"1991","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.urolonc.2008.02.016_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/1097-0142(19920401)69:7<1776::AID-CNCR2820690721>3.0.CO;2-P","article-title":"Life style and occupational risk factors for bladder cancer in Germany","volume":"69","author":"Kunze","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cncr.22071","article-title":"Bladder cancer risk as modified by family history and smoking","volume":"107","author":"Lin","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-4608(87)90270-6","article-title":"Familial bladder cancer in an oncology clinic","volume":"27","author":"Lynch","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/oxfordjournals.aje.a114331","article-title":"Bladder cancer in young women","volume":"123","author":"Piper","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0022-5347(05)65520-6","article-title":"Familial bladder cancer in the National Swedish Family Cancer Database","volume":"166","author":"Plna","year":"2001","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0090-4295(00)00905-5","article-title":"Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma","volume":"57","author":"Aben","year":"2001","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0022-5347(17)56461-7","article-title":"Familial factors in bladder carcinoma","volume":"122","author":"Lynch","year":"1979","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jnci\/51.1.269","article-title":"Environmental exposure and bladder cancer in young males","volume":"51","author":"Benton","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.02.016_bib28","series-title":"Interdisciplinary studies in the evaluation of persons at high risk of cancer","author":"Blattner","year":"1983"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-5347(17)63333-0","article-title":"Familial occurrence of carcinoma of the ureter","volume":"96","author":"Burkland","year":"1966","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2008.02.016_bib30","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/0959-8049(93)90233-6","article-title":"Urinary system tumors in a family","volume":"29A","author":"Egilsson","year":"1993","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2008.02.016_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jama.1967.03130070027006","article-title":"Malignant bladder tumors in a man and his three sons","volume":"201","author":"Fraumeni","year":"1967","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mpo.2950240411","article-title":"Genetic predisposition and cyclophosphamide treatment in a girl with bladder carcinoma?","volume":"24","author":"Kenet","year":"1995","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1055-9965.EPI-05-0714","article-title":"No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization","volume":"15","author":"Kiemeney","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jnci\/56.6.1101","article-title":"Abnormal tryptophan metabolism in a family with a history of bladder cancer","volume":"56","author":"Leklem","year":"1976","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-5347(17)54693-5","article-title":"Familial aggregation of urothelial carcinoma","volume":"126","author":"Mahboubi","year":"1981","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib36","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-5347(17)51452-4","article-title":"Familial carcinoma of ureters and other genitourinary organs","volume":"130","author":"Marchetto","year":"1983","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-5347(17)59540-3","article-title":"Familial transitional cell carcinoma of the bladder","volume":"113","author":"McCullough","year":"1975","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0090-4295(86)90400-0","article-title":"Familial transitional cell carcinoma of renal pelvis and upper ureter","volume":"27","author":"Orphali","year":"1986","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib39","first-page":"254","article-title":"Familial urinary bladder cancer","volume":"6","author":"Purtilo","year":"1979","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-5347(01)66380-8","article-title":"Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma","volume":"155","author":"Schoenberg","year":"1996","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1464-410X.1976.tb06677.x","article-title":"Familial profile of transitional cell carcinoma","volume":"48","author":"Sharma","year":"1976","journal-title":"Br J Urol"},{"issue":"9486","key":"10.1016\/j.urolonc.2008.02.016_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","article-title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses","volume":"366","author":"Garcia-Closas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2008.02.016_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1289\/ehp.792971","article-title":"N-acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology","volume":"29","author":"Lower","year":"1979","journal-title":"Environ Health Perspect"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/clpt.1983.80","article-title":"Variability in caffeine metabolism","volume":"33","author":"Grant","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.1984.tb02372.x","article-title":"A simple test for acetylator phenotype using caffeine","volume":"17","author":"Grant","year":"1984","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.urolonc.2008.02.016_bib46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/carcin\/5.9.1191","article-title":"Genetically determined debrisoquine oxidation capacity in bladder cancer","volume":"5","author":"Cartwright","year":"1984","journal-title":"Carcinogenesis"},{"issue":"20","key":"10.1016\/j.urolonc.2008.02.016_bib47","first-page":"5488","article-title":"Genetic predisposition to bladder cancer: Ability to hydroxylate debrisoquine and mephenytoin as risk factors","volume":"47","author":"Kaisary","year":"1987","journal-title":"Cancer Res"},{"issue":"5990","key":"10.1016\/j.urolonc.2008.02.016_bib48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/312169a0","article-title":"Metabolic oxidation phenotypes as markers for susceptibility to lung cancer","volume":"312","author":"Ayesh","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/1097-0142(19910701)68:1<206::AID-CNCR2820680138>3.0.CO;2-F","article-title":"A protocol for the safe administration of debrisoquine in biochemical epidemiologic research protocols for hospitalized patients","volume":"68","author":"Green-Gallo","year":"1991","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2008.02.016_bib50","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/ard.2003.019125","article-title":"Urinary bladder cancer in Wegener's granulomatosis: Risks and relation to cyclophosphamide","volume":"63","author":"Knight","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nm1010","article-title":"CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer","volume":"10","author":"Guo","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.21040","article-title":"CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas","volume":"116","author":"Schultz","year":"2005","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-0960.2006.00292.x","article-title":"Muir-Torre syndrome: Diagnostic and screening guidelines","volume":"47","author":"Jones","year":"2006","journal-title":"Austr J Dermatol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc1278","article-title":"Testing guidelines for hereditary nonpolyposis colorectal cancer","volume":"4","author":"Umar","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2008.02.016_bib55","series-title":"Hereditary neoplastic syndromes","author":"Lindor","year":"2006"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.ejhg.5201584","article-title":"Phenotypic and genotypic heterogeneity in the Lynch syndrome: Diagnostic, surveillance, and management implications","volume":"14","author":"Lynch","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1464-410X.1993.tb00683.x","article-title":"Familial transitional cell carcinoma and the Lynch syndrome II","volume":"72","author":"Greenland","year":"1993","journal-title":"Br J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(17)39853-1","article-title":"The Lynch syndrome II and urological malignancies","volume":"143","author":"Lynch","year":"1990","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib60","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(01)62926-4","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: Risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2008.02.016_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/58.2.205","article-title":"A new familial cancer syndrome?","volume":"58","author":"Chan","year":"1977","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000309401","article-title":"Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma","volume":"189","author":"Tarkkanen","year":"1984","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.2910410405","article-title":"Non-ocular cancer in patients with hereditary retinoblastoma and their relatives","volume":"41","author":"DerKinderen","year":"1988","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/bjc.1989.285","article-title":"Non-ocular cancer in relatives of retinoblastoma patients","volume":"60","author":"Sanders","year":"1989","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib65","first-page":"938","article-title":"Retinoblastoma associated with other primary malignant tumors","volume":"94","author":"Aherne","year":"1974","journal-title":"Trans Ophthalmol Soc U K"},{"issue":"5","key":"10.1016\/j.urolonc.2008.02.016_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bjc.1986.110","article-title":"Second primary neoplasms in patients with retinoblastoma","volume":"53","author":"Draper","year":"1986","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.0.CO;2-V","article-title":"Second primary tumors in patients with hereditary retinoblastoma: A register-based follow-up study, 1945\u20131994","volume":"67","author":"Moll","year":"1996","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.coc.0000128861.46357.ee","article-title":"Non-ocular second primary tumors after retinoblastoma: Retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM","volume":"27","author":"Schlienger","year":"2004","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: An overview","volume":"117","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"10.1016\/j.urolonc.2008.02.016_bib70","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.urolonc.2008.02.016_bib71","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.31430","article-title":"Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg)","volume":"140","author":"Andreou","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/bdrc.10025","article-title":"Roles of FGF receptors in mammalian development and congenital diseases","volume":"69","author":"Coumoul","year":"2003","journal-title":"Birth Defects Res C, Embryo Today"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jcb.20412","article-title":"Genetic and epigenetic aspects of bladder cancer","volume":"95","author":"Kim","year":"2005","journal-title":"J Cell Biochem"},{"issue":"9","key":"10.1016\/j.urolonc.2008.02.016_bib74","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrc1697","article-title":"Urothelial tumorigenesis: A tale of divergent pathways","volume":"5","author":"Wu","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320250309","article-title":"Gardner syndrome in a man with an interstitial deletion of 5q","volume":"25","author":"Herrera","year":"1986","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mpo.2950020404","article-title":"Sporadic bilateral retinoblastoma and 13q- chromosomal deletion","volume":"2","author":"Francke","year":"1976","journal-title":"Med Pediatr Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2008.02.016_bib77","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.ejca.2005.07.039","article-title":"Segregation analysis of urothelial cell carcinoma","volume":"42","author":"Aben","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2008.02.016_bib78","series-title":"Genetic Modifiers of Cancer Risk","author":"Caporaso","year":"2006"},{"issue":"12","key":"10.1016\/j.urolonc.2008.02.016_bib79","first-page":"1239","article-title":"Metabolic gene polymorphism frequencies in control populations","volume":"10","author":"Garte","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib80","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1176\/appi.psy.47.1.75","article-title":"Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19","volume":"47","author":"de Leon","year":"2006","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.urolonc.2008.02.016_bib82","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/carcin\/13.6.1035","article-title":"Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility","volume":"13","author":"Wolf","year":"1992","journal-title":"Carcinogenesis"},{"issue":"Spec No","key":"10.1016\/j.urolonc.2008.02.016_bib83","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00008571-199512001-00009","article-title":"The procarcinogen hypothesis for bladder cancer: Activities of individual drug metabolizing enzymes as risk factors","volume":"5","author":"Branch","year":"1995","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.urolonc.2008.02.016_bib84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00008571-200002000-00002","article-title":"CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behavior","volume":"10","author":"Saarikoski","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib85","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1086\/500848","article-title":"Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes","volume":"78","author":"Wu","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.urolonc.2008.02.016_bib86","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0215(20001101)88:3<493::AID-IJC26>3.0.CO;2-Q","article-title":"Mutagen sensitivity in patients with familial and nonfamilial urothelial cell carcinoma","volume":"88","author":"Aben","year":"2000","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2008.02.016_bib87","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jnci\/95.7.540","article-title":"Genetic instability in bladder cancer assessed by the comet assay","volume":"95","author":"Schabath","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.urolonc.2008.02.016_bib88","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/carcin\/bgi063","article-title":"Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer","volume":"26","author":"Broberg","year":"2005","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.urolonc.2008.02.016_bib89","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1055-9965.EPI-06-0961","article-title":"Telomere length, cigarette smoking, and bladder cancer risk in men and women","volume":"16","author":"McGrath","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"10.1016\/j.urolonc.2008.02.016_bib90","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/djg011","article-title":"Telomere dysfunction: A potential cancer predisposition factor","volume":"95","author":"Wu","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.02.016_bib91","first-page":"479","article-title":"Scanning the horizon: What is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention?","volume":"18","author":"Hunter","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2008.02.016_bib92","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/510686","article-title":"Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide polymorphism association studies","volume":"80","author":"Pearson","year":"2007","journal-title":"Am J Hum Genet"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:54:38Z","timestamp":1761040478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143908000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1078143908000665"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.02.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial and genetic risk of transitional cell carcinoma of the urinary tract","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}